Sector valuations Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
09:07:18 22/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2,777.30 INR | +0.75% |
|
+8.04% | +51.10% |
| 15/08 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 12/08 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 34.48x | 4.83x | 2.58x | 6.47x | 22.44x | 27.17x | 0.91% | 46.81B | |
| 15.9x | 1.77x | 7.61x | 1.97x | 8.74x | 11.09x | 1.7% | 37.1B | |
| 27.84x | 3.83x | -1.66x | 3.97x | 16.45x | 23.04x | 0.58% | 12.09B | |
| 26.98x | 2.98x | 3.84x | 3.27x | 16.95x | 21.75x | 0.94% | 11.69B | |
| 18.58x | 3.38x | 3.15x | 3.37x | 11.75x | 13.98x | 3.79% | 9.03B | |
| 9.49x | 1.56x | 1.37x | 2.2x | 5.69x | 6.92x | 4.68% | 7.45B | |
| 29.8x | 5.47x | 0.42x | 3.9x | 18.14x | 21.87x | 0.16% | 7.22B | |
| 15.18x | 1.27x | 2.52x | 2.01x | 6.67x | 9.46x | 3.28% | 7.13B | |
| 35.33x | 8.17x | 1.9x | 6.89x | 25.19x | 27.81x | 0.98% | 4.62B | |
| 16.7x | 0.81x | -0.03x | 2.28x | 9.77x | 12.36x | 1.62% | 4.49B | |
| 14.44x | 2.42x | 0.53x | 2.4x | 10.77x | 10.6x | 3.64% | 3.8B | |
| 15.84x | 2.81x | -9.44x | 3.2x | 12.06x | 14.39x | 3.08% | 2.77B | |
| 19.16x | 4.86x | 4.31x | 5.46x | 16.37x | 17.91x | 3.15% | 2.47B | |
| 13.09x | - | -0.86x | 9.14x | 8.97x | 9.24x | - | 2.31B | |
| 30.03x | - | -0.12x | - | - | - | - | 2.33B | |
| Average | 21.52x | 3.40x | 1.07x | 4.04x | 13.57x | 16.26x | 2.19% | 10.75B | |
| Weighted average by Cap. | 24.19x | 3.41x | 2.98x | 4.06x | 15.06x | 18.55x | 1.66% |
Select your edition
All financial news and data tailored to specific country editions
